Alvotech (ALVO)
USD 8.53
(-2.96%)
USD 8.53
(-2.96%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.88 Billion USD | 35.16% |
| 2022 | 1.39 Billion USD | 89.87% |
| 2021 | 733.58 Million USD | -45.32% |
| 2020 | 1.34 Billion USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.67 Billion USD | -2.62% |
| 2024 Q1 | 1.71 Billion USD | -8.66% |
| 2023 Q2 | 1.38 Billion USD | -10.45% |
| 2023 FY | 1.88 Billion USD | 35.16% |
| 2023 Q4 | 1.88 Billion USD | 16.23% |
| 2023 Q3 | 1.61 Billion USD | 16.59% |
| 2023 Q1 | 1.55 Billion USD | 11.37% |
| 2022 Q1 | 22.48 Million USD | -96.93% |
| 2022 FY | 1.39 Billion USD | 89.87% |
| 2022 Q4 | 1.39 Billion USD | 45.04% |
| 2022 Q3 | 960.35 Million USD | -10.31% |
| 2022 Q2 | 1.07 Billion USD | 4661.98% |
| 2021 Q3 | 22.2 Million USD | -5.14% |
| 2021 Q4 | 733.58 Million USD | 3203.37% |
| 2021 Q2 | 23.41 Million USD | 0.17% |
| 2021 Q1 | 23.37 Million USD | -23.64% |
| 2021 FY | 733.58 Million USD | -45.32% |
| 2020 Q2 | 335.41 Million USD | 0.0% |
| 2020 Q1 | 335.41 Million USD | 0.0% |
| 2020 Q4 | 30.6 Million USD | -90.88% |
| 2020 Q3 | 335.41 Million USD | 0.0% |
| 2020 FY | 1.34 Billion USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 947.87 Million USD | -98.61% |
| Embecta Corp. | 2.03 Billion USD | 7.54% |
| ANI Pharmaceuticals, Inc. | 471.67 Million USD | -299.129% |
| Dynavax Technologies Corporation | 375.02 Million USD | -401.99% |
| Esperion Therapeutics, Inc. | 660.79 Million USD | -184.899% |
| Pacira BioSciences, Inc. | 704.25 Million USD | -167.315% |
| PainReform Ltd. | 2.69 Million USD | -69858.491% |
| Aquestive Therapeutics, Inc. | 163.9 Million USD | -1048.582% |
| Sunshine Biopharma, Inc. | 6.13 Million USD | -30562.958% |
| SCYNEXIS, Inc. | 55.45 Million USD | -3295.1% |
| China SXT Pharmaceuticals, Inc. | 9.19 Million USD | -20370.399% |
| Cosmos Health Inc. | 30.25 Million USD | -6122.895% |
| Journey Medical Corporation | 56.49 Million USD | -3232.064% |
| Sunshine Biopharma, Inc. | 6.13 Million USD | -30562.958% |
| Safety Shot Inc | 3.89 Million USD | -48270.034% |
| Alpha Teknova, Inc. | 38.55 Million USD | -4783.357% |
| Intra-Cellular Therapies, Inc. | 136.87 Million USD | -1275.443% |
| Bright Green Corporation | 6.43 Million USD | -29141.273% |
| Procaps Group, S.A. | 462.06 Million USD | -307.428% |
| Theratechnologies Inc. | 98.63 Million USD | -1808.558% |
| Harrow Health, Inc. | 241.75 Million USD | -678.722% |
| Sonoma Pharmaceuticals, Inc. | 8.75 Million USD | -21400.491% |
| Biofrontera Inc. | 23.13 Million USD | -8035.974% |
| DURECT Corporation | 30.4 Million USD | -6091.485% |
| Supernus Pharmaceuticals, Inc. | 487.46 Million USD | -286.202% |
| Cronos Group Inc. | 43.73 Million USD | -4204.416% |
| OptiNose, Inc. | 194.33 Million USD | -868.731% |
| Ironwood Pharmaceuticals, Inc. | 817.36 Million USD | -130.323% |
| Kala Pharmaceuticals, Inc. | 48.44 Million USD | -3786.021% |
| RedHill Biopharma Ltd. | 20.97 Million USD | -8874.029% |
| Organogenesis Holdings Inc. | 181.36 Million USD | -938.025% |
| Guardion Health Sciences, Inc. | 3.77 Million USD | -49807.638% |
| Cumberland Pharmaceuticals Inc. | 52.51 Million USD | -3484.766% |
| Radius Health, Inc. | 804.29 Million USD | -134.068% |
| Universe Pharmaceuticals INC | 13.75 Million USD | -13587.202% |
| ProPhase Labs, Inc. | 42.54 Million USD | -4325.026% |
| Phibro Animal Health Corporation | 725.54 Million USD | -159.472% |
| Procaps Group S.A. | 462.06 Million USD | -307.428% |
| TherapeuticsMD, Inc. | 14.02 Million USD | -13325.924% |
| Viatris Inc. | 27.21 Billion USD | 93.083% |
| Rockwell Medical, Inc. | 30.88 Million USD | -5996.053% |
| Aytu BioPharma, Inc. | 90.37 Million USD | -1982.987% |
| SIGA Technologies, Inc. | 57.97 Million USD | -3147.104% |
| Tilray Brands, Inc. | 892.11 Million USD | -111.024% |
| Lifecore Biomedical, Inc. | 219.8 Million USD | -756.498% |
| Shineco, Inc. | 47.6 Million USD | -3854.866% |
| PetIQ, Inc. | 645.22 Million USD | -191.77% |
| Regencell Bioscience Holdings Limited | 219.51 Thousand USD | -857521.907% |
| Incannex Healthcare Limited | 5.83 Million USD | -32191.304% |
| Neurocrine Biosciences, Inc. | 1.01 Billion USD | -84.676% |
| Alimera Sciences, Inc. | 107.35 Million USD | -1653.622% |
| Silver Spike Investment Corp. | 3 Million USD | -62447.798% |
| Assertio Holdings, Inc. | 148.41 Million USD | -1168.45% |
| Shuttle Pharmaceuticals Holdings, Inc. | 1.89 Million USD | -99194.185% |
| Petros Pharmaceuticals, Inc. | 21.31 Million USD | -8731.878% |
| Clever Leaves Holdings Inc. | 7.02 Million USD | -26694.52% |
| Cyclo Therapeutics, Inc. | 8.49 Million USD | -22072.736% |
| Avadel Pharmaceuticals plc | 173.38 Million USD | -985.769% |
| Hempacco Co., Inc. | 18.82 Million USD | -9901.82% |
| Talphera, Inc. | 6.29 Million USD | -29829.777% |
| Alvotech | 1.88 Billion USD | 0.0% |
| Eagle Pharmaceuticals, Inc. | 172.6 Million USD | -990.72% |
| Lantheus Holdings, Inc. | 835.25 Million USD | -125.39% |
| Currenc Group, Inc. | 177.67 Million USD | -959.561% |
| Kamada Ltd. | 109.96 Million USD | -1611.933% |
| Indivior PLC | 1.95 Billion USD | 3.519% |
| Evoke Pharma, Inc. | 9.64 Million USD | -19412.508% |
| Flora Growth Corp. | 17.22 Million USD | -10831.268% |
| Cyclo Therapeutics, Inc. | 8.49 Million USD | -22072.736% |
| Evolus, Inc. | 209.68 Million USD | -797.806% |
| HUTCHMED (China) Limited | 536.38 Million USD | -250.975% |
| Amphastar Pharmaceuticals, Inc. | 873.49 Million USD | -115.524% |
| Akanda Corp. | 12.66 Million USD | -14759.895% |